Nurexone Biologic Inc (NRX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 700 | 2,523 | 2,385 | 3,255 | 541 |
| Receivables | 127 | 259 | 358 | 390 | 98 |
| Other current assets | 41 | 41 | 41 | 32 | 1,229 |
| TOTAL | $1,634 | $2,823 | $2,784 | $3,677 | $1,982 |
| Non-Current Assets | |||||
| PPE Net | 807 | 791 | 508 | 465 | 188 |
| TOTAL | $807 | $791 | $508 | $465 | $188 |
| Total Assets | $2,441 | $3,614 | $3,292 | $4,142 | $2,170 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accrued Expenses | 339 | 172 | 173 | 231 | 548 |
| Other current liabilities | N/A | N/A | N/A | N/A | 1,197 |
| TOTAL | $398 | $435 | $546 | $362 | $1,908 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 0 | 0 | 2 | 29 | 95 |
| Other Non-Current Liabilities | 78 | 71 | 64 | 78 | 71 |
| TOTAL | $282 | $251 | $171 | $149 | $73 |
| Total Liabilities | $680 | $686 | $717 | $511 | $1,981 |
| Shareholders' Equity | |||||
| Retained earnings | -19,100 | -17,554 | -16,304 | -14,979 | -14,057 |
| Other shareholders' equity | 1,395 | 2,699 | 2,051 | 2,113 | 2,084 |
| TOTAL | $1,761 | $2,928 | $2,575 | $3,631 | $189 |
| Total Liabilities And Equity | $2,441 | $3,614 | $3,292 | $4,142 | $2,170 |